Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS Status
{{output}}
Background/aim: The first-line treatment for platinum-sensitive recurrent or metastatic head and neck cancer (R/M HNSCC) is pembrolizumab with or without chemotherapy. The decision to combine chemotherapy largely depends on progr... ...
